Author pages are created from data sourced from our academic publisher partnerships and public sources.
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
- A. Kastrati, F. Neumann, +15 authors A. Schoemig
- The New England journal of medicine
- 14 August 2008
BACKGROUND Whether bivalirudin is superior to unfractionated heparin in patients with stable or unstable angina who undergo percutaneous coronary intervention (PCI) after pretreatment with… Expand
Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis.
AIMS The objective of this study was to assess the non-inferiority, in terms of anti-restenotic efficacy, of both biodegradable-polymer (BP) and polymer-free (PF) stents compared with… Expand
Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer.
OBJECTIVES We sought to assess changes in antirestenotic efficacy of drug-eluting stents (DES) by restudying subjects at 2 time points after coronary stenting (6 to 8 months and 2 years) and to… Expand
A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
AIMS Long-term polymer residue in the coronary milieu is a consequence of current drug-eluting stent (DES) therapy and has been implicated in late adverse events. We developed a novel polymer-free… Expand
Carotid artery intima-media thickness and plaque score can predict the SYNTAX score.
AIMS There are few reports demonstrating a relationship between carotid artery ultrasound (carotid-US) findings and the complexity of coronary artery disease. We aimed to examine the relationship… Expand
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
- J. Mehilli, A. Kastrati, +9 authors A. Schoemig
- Journal of the American College of Cardiology
- 12 May 2009
OBJECTIVES The aim of this trial was to compare the safety and efficacy of paclitaxel-eluting stents (PES) and sirolimus-eluting stents (SES) for treatment of unprotected left main coronary artery… Expand
Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
BACKGROUND Diabetes mellitus is associated with an increased risk of restenosis, stent thrombosis, and death after percutaneous coronary interventions. Little is known about the late outcome of… Expand
Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes.
AIMS Percutaneous treatment of coronary bifurcation disease remains challenging. In patient subsets in which a two-stent strategy is necessary, the culotte technique is a widely used method. We… Expand
Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation
Objectives. Optimal antithrombotic/anticoagulation therapy in patients on chronic oral anticoagulation (OAC) undergoing drug‐eluting stent (DES) implantation is unknown. We investigated the efficacy… Expand
Chronic stent recoil plays an important role in restenosis of the right coronary ostium
ObjectiveThe efficacy of coronary stenting of aorto-ostial atherosclerotic lesions is still unclear. We investigated the frequency and mechanism of stent restenosis at this particular lesion.… Expand